Codiak Biosciences Competitors and Similar CompaniesClear all
Codiak Biosciences's competitors and similar companies include Nimbus Therapeutics, AstraZeneca and ArunA Bio.
 Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. |  Nimbus Therapeutics Nimbus Therapeutics is a biotechnology company which operates an application of computational chemistry to design treatments for substantial and underserved human diseases. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  ArunA Bio ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules. | |
Founding Date | Founding Date 2015 | Founding Date 2009 | Founding Date 1999 | Founding Date 2003 |
Type | Type Public | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Cambridge, US HQ | Locations Cambridge, US HQ | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations Athens, US HQ Athens, US |
Employees | Employees 992% decrease | Employees 1091% increase | Employees 94,300 | Employees 274% increase |
Valuation ($) | Valuation ($) 2.8 m | Valuation ($) N/A | Valuation ($) 2.7 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $22.9m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($37.2m) (FY, 2021) | Net income N/A | Net income $10.2b (FY, 2025) | Net income N/A |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 105m (almost 5 years ago) | Latest funding round N/A | Latest funding round $ 4.5m (over 6 years ago) |
Total funding raised | Total funding raised $ 168.5m | Total funding raised $ 242m | Total funding raised $ 1b | Total funding raised $ 26.9m |
For sources of this data, please see the company profile
View Company Profiles
Nimbus Therapeutics
HQ
Cambridge, US
Employees
109↑ 1% increase
Nimbus Therapeutics is a biotechnology company which operates an application of computational chemistry to design treatments for substantial and underserved human diseases.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View companyArunA Bio
HQ
Athens, US
Employees
27↑ 4% increase
ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules.
View company